CHAMPIONS ONCOLOGY, INC. (CSBR)
Biological Products, (No Diagnostic Substances) · Healthcare · $96M
Intrinsic Value (Consensus)
$5.91
Current Price
$6.88
Margin of Safety
-14.1%
14.1% Above Intrinsic Value
Value: $6
Price: $7
Valuation Model Estimates
Current Price: $6.88
DCF (Discounted Cash Flow)
$7.93
Graham Number
$1.42
Earnings Power Value
$3.20
Relative Value (P/E)
$6.60
Dividend Discount Model
Not applicable
—
Consensus Value
$5.91
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
67
Profitability
25/25
Strength
17/25
Valuation
12/25
Growth
13/25
Financial Health Signals
Strong profitability — ROE of 125% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $0.33
- EPS (Forward)
- $0.35
- Book Value
- $0.27
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 124.6%
- Debt/Equity
- —
- Revenue Growth
- 13.5%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance